55 Biggest Movers From Yesterday
Gainers
Reliance Global Group, Inc. (NASDAQ: RELI) shares jumped 78.7% to close at $5.45 on Tuesday after gaining around 6% on Monday.
BioVie Announces Partnership With The American Liver Foundation
BioVie Inc., (NASDAQ:BIVI) ("BioVie" or the "Company"), a clinical-stage company developing innovative drug therapies for the treatment of advanced liver disease and neurological and neurodegenerative
B. Riley Securities Maintains Buy on BioVie, Lowers Price Target to $27
B. Riley Securities analyst Mayank Mamtani maintains BioVie (NASDAQ:BIVI) with a Buy and lowers the price target from $50 to $27.
61 Biggest Movers From Yesterday
Gainers
Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ: IINN) shares surged 308.1% to settle at $9.59 on Tuesday after the company signed an agreement with Waas Group for the development 1,040 ART systems in Spain and Portugal.
Why Did BioVie Shares Jump 21% Today?
The FDA has signed off BioVie Inc’s (NASDAQ:BIVI) Phase 2 study assessing NE3107’s potential pro-motoric impact in Parkinson’s disease patients. The…
BioVie Reports FDA Authorization To Initiate Phase 2 Trials Assessing NE3107’s Pro-Motoric Activity In Parkinson’s Disease
BioVie Inc., (NASDAQ:BIVI) (“BioVie” or the “Company”) a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders and advanced
BioVie Sponsored Study Titled ‘NE3107 Activity and Safety in Patients With Parkinson’s Disease Using Levodopa’ Posted To ClinicalTrials.Gov; Study Not Yet Recruiting
https://clinicaltrials.gov/ct2/show/NCT05083260
The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Oct. 11)
The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Oct. 7)